Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

Download All
In this online program based on a series of CLL Webinars, experts discuss evidence-based best practices in using BTK inhibitors to treat patients with CLL. Watch the on-demand Webcast and download the slides now.
Danielle Brander, MD
Nicole Lamanna, MD
Jeff P. Sharman, MD

Podcasts

Listen to CLL experts Jeff Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from live CCO Webinars on optimizing BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL).

Danielle Brander, MD Nicole Lamanna, MD Jeff P. Sharman, MD Released: September 17, 2020

Hear from experts Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, as they answer audience questions from the second in a series of live CCO Webinars on optimizing BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL).

Danielle Brander, MD Nicole Lamanna, MD Jeff P. Sharman, MD Released: September 16, 2020

Hear from experts Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, as they answer audience questions from the third in a series of live CCO Webinars on optimizing BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL).

Danielle Brander, MD Nicole Lamanna, MD Jeff P. Sharman, MD Released: September 17, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings